Generation and characterization of the Anp32e-deficient mouse

PLoS ONE

Volumn 5, Issue 10, 2010, Pages

  Reilly, Patrick T ^a,b   Afzal, Samia ^b,c   Wakeham, Andrew ^b   Haight, Jillian ^b   You Ten, Annick ^b   Zaugg, Kathrin ^b,d   Dembowy, Joanna ^b,e   Young, Ashley ^b   Mak, Tak W ^a,b  

^a DIVISION OF MEDICAL ONCOLOGY   (Singapore)

^b UNIVERSITY HEALTH NETWORK   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^e MOUNT SINAI HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL WELLBEING; ANP32A GENE; ANP32E GENE; APOPTOSIS; ARTICLE; CELL GROWTH; CELL STRESS; CONTROLLED STUDY; EMBRYO; FEMALE; FETUS; FIBROBLAST; GENE; GENE DELETION; GENE FUNCTION; MALE; MOUSE; MOUSE STRAIN; MULTIGENE FAMILY; NONHUMAN; PATHOGENESIS; PHYSICAL CAPACITY; THYMOCYTE; ANIMAL; C57BL MOUSE; GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VALIDATION STUDY;

MUS; VERTEBRATA;

ANP32B PROTEIN, MOUSE; CELL CYCLE PROTEIN; NERVE PROTEIN; NUCLEAR PROTEIN;

ANIMALS; CELL CYCLE PROTEINS; MICE; MICE, INBRED C57BL; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78149462006     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0013597     Document Type: Article

References (41)

1. Adegbola O, Pasternack GR (2005) Phosphorylated retinoblastoma protein complexes with pp32 and inhibits pp32-mediated apoptosis. J Biol Chem 280: 15497-15502.
2. Amasaki H, Ogawa M, Nagasao J, Mutoh K, Ichihara N, et al. (2003) Distributional changes of BrdU, PCNA, E2F1 and PAL31 molecules in developing murine palatal rugae. Ann Anat 185: 517-523.
3. Fan Z, Zhang H, Zhang Q (2006) Tumor suppressor pp32 represses cell growth through inhibition of transcription by blocking acetylation and phosphorylation of histone H3 and initiating its proapoptotic activity. Cell Death Differ 13: 1485-1494.
4. Malek SN, Katumuluwa AI, Pasternack GR (1990) Identification and preliminary characterization of two related proliferation-associated nuclear phosphoproteins. J Biol Chem 265: 13400-13409.
5. Sun W, Hattori N, Mutai H, Toyoshima Y, Kimura H, et al. (2001) PAL31, a nuclear protein required for progression to the S phase. Biochem Biophys Res Commun 280: 1048-1054.
6. Beresford PJ, Zhang D, Oh DY, Fan Z, Greer EL, et al. (2001) Granzyme A activates an endoplasmic reticulum-associated caspase-independent nuclease to induce single-stranded DNA nicks. J Biol Chem 276: 43285-43293.
7. Fan Z, Beresford PJ, Oh DY, Zhang D, Lieberman J (2003) Tumor suppressor NM23-H1 is a granzyme A-activated DNase during CTL-mediated apoptosis, and the nucleosome assembly protein SET is its inhibitor. Cell 112: 659-672.
8. Hill MM, Adrain C, Duriez PJ, Creagh EM, Martin SJ (2004) Analysis of the composition, assembly kinetics and activity of native Apaf-1 apoptosomes. EMBO J 23: 2134-2145.
9. Jiang X, Kim HE, Shu H, Zhao Y, Zhang H, et al. (2003) Distinctive roles of PHAP proteins and prothymosin-alpha in a death regulatory pathway. Science 299: 223-226.
10. Schafer ZT, Parrish AB, Wright KM, Margolis SS, Marks JR, et al. (2006) Enhanced sensitivity to cytochrome c-induced apoptosis mediated by PHAPI in breast cancer cells. Cancer Res 66: 2210-2218.
11. Sun W, Kimura H, Hattori N, Tanaka S, Matsuyama S, et al. (2006) Proliferation related acidic leucine-rich protein PAL31 functions as a caspase-3 inhibitor. Biochem Biophys Res Commun 342: 817-823.
12. Hoffarth S, Zitzer A, Wiewrodt R, Hahnel PS, Beyer V, et al. (2008) pp32/ PHAPI determines the apoptosis response of non-small-cell lung cancer. Cell Death Differ 15: 161-170
13. Pan W, da Graca LS, Shao Y, Yin Q, Wu H, et al. (2009) PHAPI/pp32 suppresses tumorigenesis by stimulating apoptosis. J Biol Chem 284: 6946-6954.
14. Anisimov SV, Tarasov KV, Tweedie D, Stern MD, Wobus AM, et al. (2002) SAGE identification of gene transcripts with profiles unique to pluripotent mouse R1 embryonic stem cells. Genomics 79: 169-176.
15. Brody JR, Kadkol SS, Hauer MC, Rajaii F, Lee J, et al. (2004) pp32 reduction induces differentiation of TSU-Pr1 cells. Am J Pathol 164: 273-283
16. Radrizzani M, Vila-Ortiz G, Cafferata EG, Di Tella MC, Gonzalez-Guerrico A, et al. (2001) Differential expression of CPD1 during postnatal development in the mouse cerebellum. Brain Res 907: 162-174.
17. Puente LG, Carriere JF, Kelly JF, Megeney LA (2004) Comparative analysis of phosphoprotein-enriched myocyte proteomes reveals widespread alterations during differentiation. FEBS Lett 574: 138-144.
18. Kular RK, Cvetanovic M, Siferd S, Kini AR, Opal P (2009) Neuronal differentiation is regulated by leucine-rich acidic nuclear protein (LANP), a member of the inhibitor of histone acetyltransferase complex. J Biol Chem 284: 7783-7792.
19. Costanzo RV, Vila-Ortiz GJ, Perandones C, Carminatti H, Matilla A, et al. (2006) Anp32e/Cpd1 regulates protein phosphatase 2A activity at synapses during synaptogenesis. Eur J Neurosci 23: 309-324.
20. Fukukawa C, Tanuma N, Okada T, Kikuchi K, Shima H (2005) pp32/I-1(PP2A) negatively regulates the Raf-1/MEK/ERK pathway. Cancer Lett 226: 155-160.
21. Li M, Guo H, Damuni Z (1995) Purification and characterization of two potent heat-stable protein inhibitors of protein phosphatase 2A from bovine kidney. Biochemistry 34: 1988-1996.
22. Fries B, Heukeshoven J, Hauber I, Gruttner C, Stocking C, et al. (2007) Analysis of nucleocytoplasmic trafficking of the HuR ligand APRIL and its influence on CD83 expression. J Biol Chem 282: 4504-4515.
23. Gallouzi IE, Brennan CM, Steitz JA (2001) Protein ligands mediate the CRM1-dependent export of HuR in response to heat shock. RNA 7: 1348-1361.
24. Higashino F, Aoyagi M, Takahashi A, Ishino M, Taoka M, et al. (2005) Adenovirus E4orf6 targets pp32/LANP to control the fate of ARE-containing mRNAs by perturbing the CRM1-dependent mechanism. J Cell Biol 170: 15-20.
25. Itin C, Ulitzur N, Muhlbauer B, Pfeffer SR (1999) Mapmodulin, cytoplasmic dynein, and microtubules enhance the transport of mannose 6-phosphate receptors from endosomes to the trans-golgi network. Mol Biol Cell 10: 2191-2197.
26. Opal P, Garcia JJ, Propst F, Matilla A, Orr HT, et al. (2003) Mapmodulin/ leucine-rich acidic nuclear protein binds the light chain of microtubule-associated protein 1B and modulates neuritogenesis. J Biol Chem 278: 34691-34699.
27. Seo SB, Macfarlan T, McNamara P, Hong R, Mukai Y, et al. (2002) Regulation of histone acetylation and transcription by nuclear protein pp32, a subunit of the INHAT complex. J Biol Chem 277: 14005-14010.
28. Schneider R, Bannister AJ, Weise C, Kouzarides T (2004) Direct binding of INHAT to H3 tails disrupted by modifications. J Biol Chem 279: 23859-23862.
29. Cvetanovic M, Rooney RJ, Garcia JJ, Toporovskaya N, Zoghbi HY, et al. (2007) The role of LANP and ataxin 1 in E4F-mediated transcriptional repression. EMBO Rep 8: 671-677.
30. Matilla A, Radrizzani M (2005) The Anp32 family of proteins containing leucine-rich repeats. Cerebellum 4: 7-18.
31. Santa-Coloma TA (2003) Anp32e (Cpd1) and related protein phosphatase 2 inhibitors. Cerebellum 2: 310-320.
32. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, et al. (2008) Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 216: 471-482.
33. Walker BA, Leone PE, Chiecchio L, Dickens NJ, Jenner NW, et al. A compendium of myeloma associated chromosomal copy number abnormalities and their prognostic value. Blood.
34. Bjorck E, Ek S, Landgren O, Jerkeman M, Ehinger M, et al. (2005) High expression of cyclin B1 predicts a favorable outcome in patients with follicular lymphoma. Blood 105: 2908-2915.
35. Buszczak M, Paterno S, Lighthouse D, Bachman J, Planck J, et al. (2007) The carnegie protein trap library: a versatile tool for Drosophila developmental studies. Genetics 175: 1505-1531.
36. Opal P, Garcia JJ, McCall AE, Xu B, Weeber EJ, et al. (2004) Generation and characterization of LANP/pp32 null mice. Mol Cell Biol 24: 3140-3149.
37. Jiang M, Ma Y, Ni X, Cao G, Ji C, et al. (2002) Molecular cloning and characterization of a novel human gene (ANP32E alias LANPL) from human fetal brain. Cytogenet Genome Res 97: 68-71.
38. Ruland J, Sirard C, Elia A, MacPherson D, Wakeham A, et al. (2001) p53 accumulation, defective cell proliferation, and early embryonic lethality in mice lacking tsg101. Proc Natl Acad Sci U S A 98: 1859-1864
39. Okada H, Suh WK, Jin J, Woo M, Du C, et al. (2002) Generation and characterization of Smac/DIABLO-deficient mice. Mol Cell Biol 22: 3509-3517.
40. Hao Z, Duncan GS, Chang CC, Elia A, Fang M, et al. (2005) Specific ablation of the apoptotic functions of cytochrome C reveals a differential requirement for cytochrome C and Apaf-1 in apoptosis. Cell 121: 579-591.
41. Reilly PT, Herr W (2002) Spontaneous reversion of tsBN67 cell proliferation and cytokinesis defects in the absence of HCF-1 function. Exp Cell Res 277: 119-130.